Car T Cell Therapy: Revolutionizing Cancer Treatment
CAR T Cell Therapy, short for chimeric antigen receptor T cell therapy, represents a groundbreaking approach in the field of cancer treatment. This innovative immunotherapy harnesses the power of a patient's own immune system to combat cancer cells. With its remarkable success in treating certain types of leukemia and lymphoma, CAR T cell therapy has emerged as a game-changer, offering new hope to patients who have exhausted conventional treatment options. In this article, we will explore the concept of CAR T cell therapy, its mechanism of action, successes, challenges, and its potential for the future of cancer care.
CAR T Cell Therapy involves reprogramming a patient's T cells, a type of white blood cell, to target and eliminate cancer cells. The process begins by collecting the patient's T cells through a blood sample. These T cells are then genetically modified in a laboratory to express a chimeric antigen receptor (CAR) on their surface. The CAR is designed to recognize specific proteins, known as antigens, that are present on the surface of cancer cells.
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian